CPHI Milan is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa
Informa

CPHI Celebration 2024

The CPHI Pharma Awards

What to expect

Network, connect, relax!

CPHI Celebration includes our annual Pharma Awards ceremony, recognising the teams, individuals and companies whose products and solutions enable purposeful change within our industry.

Worldwide recognition
Exposure amongst pharma’s most talented
Global media coverage and promotion
Explore new business opportunities
Sponsorship
Pharma Awards
Who can submit an entry?
The CPHI Pharma Awards are free to enter and open to pharma and biopharma companies from across the global pharma supply chain. You don't need to be an exhibitor at CPHI Milan to enter.

Entry Guide

Our entry guide has been designed to help you navigate the 14 CPHI Pharma Awards categories. Explore the guide today to discover where your innovation or solution belongs, and the information you need to provide to deliver the best possible submission!

Remember - it's completely free to enter, and open to both exhibitors and non-exhibitors.

How to enter
Pre-submission

Got what it takes?

All entries must be based on activities undertaken between 30 June 2023 – August 2024 (See criteria for full eligibility details).

Submissions are NOW CLOSED

Submission entries are now closed and shortlisted entries will be notified by mid-September. 

Shortlist revealed - September 2024

Who is in the running?

Discover the companies in line for the prize!

This year’s shortlist will be revealed in September. Finalists will be notified individually.

Winners announced - 8th October 2024

Let's raise a toast!

A glamorous drinks reception kicks off the award ceremony at the end of day 1 at Alcatraz Milano, where we announce the winners and celebrate each of their achievements.

Categories for 2024
This year, the CPHI Pharma Awards will recognise excellence across the following categories along with the judges:
Accelerating Innovation

Recognising innovation in technologies, products, processes, and services to combat the impact of global healthcare emergencies on individuals, patients, healthcare professionals and communities. Including but not limited to drug or device development, rapid response, medical equipment and the introduction of services, solutions and resources to combat the impact of past and potential healthcare emergencies.

Criteria:

Innovation
How does the entry demonstrate innovation and resourcefulness in response to healthcare emergencies? Will it inspire future development?

Purpose and Outcomes
Does it achieve its purpose? Does it offer benefits to the audience it was designed for?

Problem-solving
Does the entry demonstrate a unique approach to solving a particular challenge?

Competitive Advantage
How does the entry demonstrate going above and beyond or a collaborative approach in a time of crisis?


Judges:
Michael Nieuwesteeg, Managing Director, NVC Packaging Centre
Anita Vasilevska, Technical Marketing Manager, IMCD
Phillip Broadwith, Business Editor, Royal Society of Chemistry
Vincent Galand, Head of BD & Partnerships France, Observia
Mayur Patel, Associate Partner, PA Consulting
Viju Vasishta, Sustainable Materials & Packaging Lead, PA Consulting

API Development & Innovation

Innovation in technologies, products, processes, and services for the development and manufacture of active pharmaceutical ingredients including, but not limited to, synthesis, characterization, scale-up, software and database development, bulk manufacturing.

Criteria:

Innovation
Does the entry introduce a new idea, method or process to the market? Will it inspire broader applications?

Purpose
Does it achieve its purpose? Does it offer clear benefits or improvements over existing solutions?

Problem-solving
Does it solve a problem? Does it address an issue in an effective way?

Competitive Advantage
Does it offer a competitive advantage in the market and within its category?


Judges:
Michael McCoy, Executive Editor, Business & Policy, Chemical & Engineering News
Enric Bosch Rado, Senior EHS Manager - Supplier Qualification and Auditing, Boehringer Ingleheim
Harsh Chauhan, Assistant Professor, Creighton University
Anita Vasilevska, Technical Marketing Manager, IMCD
Molly Bowman, Head of Strategy for Pharmaceutical Supply Chain Management, Clarivate
Edgar Pogna, Principal, L.E.K. Consulting GmbH
Elisabeth Stampa, President Medicines for Europe and Chair, Medichem SA

Finished Formulation

Innovation in technologies, products, processes, and services related to the formulation of drug products including, but not limited to, excipients, finished dose, OTC, novel software and digitilisation, process development, resolving formulation challenges, bioavailability enhancement, drug targeting or controlled release and stabilization technologies.

Please note: to be eligible for this category, the activity must have taken place between Jan 2022 - August 2023.

 

Criteria

Innovation
Does the entry introduce a new idea, method, or novelty to the market?

Purpose
Does it achieve its purpose? Does it offer clear benefits or improvements over existing solutions?

Problem-solving
Does it solve a problem? Does it address an issue in an effective way?

Competitive Advantage
Does it offer a competitive advantage in the market and within its category?


Judges:
Orlaith Ryan, CTO, Shorla Pharma
Harsh Chauhan, Assistant Professor, Creighton University
Anita Vasilevska, Technical Marketing Manager, IMCD
Edgar Pogna, Principal, L.E.K. Consulting GmbH

Manufacturing Excellence

Innovation in technologies, processes, and services for the manufacture of solid, semi-solid, parenteral, inhalation, or other dosage drugs including, but not limited to, equipment, approaches,digitilisation, manufacturing processes, facilities, tech transfer and process controls. We welcome entries across both small and large molecule manufacturing.

 

Criteria

Innovation
Does the entry introduce a new idea, process, method, or novelty to the market? Will it inspire future development?

Features
Does the entry have unique qualities, abilities, or significantly improved attributes?

Problem-solving
Does it solve a problem? Does it address an issue in an effective way?

Competitive Advantage
Does it offer a competitive advantage in the market and within its category?


Judges:
Fiona Barry, Editor-in-Chief and Director – PharmSource, GlobalData
Dan Stanton, Editorial Director, Informa Connect Life Sciences
Bikash Chatterjee, President & CSO, Pharmatech
Molly Bowman, Head of Strategy for Pharmaceutical Supply Chain Management, Clarivate
Elisabeth Stampa, President Medicines for Europe and Chair, Medichem SA

Drug Delivery & Device Innovation

Innovation in technologies, products, solutions, processes, and services related to drug delivery, routes of administration and device innovation. Including, but not limited to, inhalers, auto-injectors, pre-filled syringes, patches, combination products, intelligent packaging and connected devices.

 

Criteria

Innovation
Does the entry introduce a new idea, device, method or novelty to the market? Will it inspire future development?

Features & Purpose
Does the entry have unique qualities, abilities, or improved attributes? Does it offer a significant improvement on existing market solutions?

Patient Centricity
Does the entry offer tangible improvements to patient adherence and experience?

Problem-solving
Does it solve a problem? Does it address an issue in an effective way?

Competitive Advantage
Does it offer a competitive advantage in the market and within its category?


Judges:
Wayne Weiner, President, Pharmatech Solutions LLC
Pascale Gauthier, Pharmacist, PhD, Auvergne University
Emil Ciurczak, President, Doramaxx Consulting
Duncan Emerton, Consulting & Analytics, Citeline
Harsh Chauhan, Assistant Professor, Creighton University
Michael Nieuwesteeg, Managing Director, NVC Packaging Centre
Anita Vasilevska, Technical Marketing Manager, IMCD
Mayur Patel, Associate Partner, PA Consulting
Soroosh Bagheriasl, Senior Account Manager, MediPhorum

Packaging & Machinery

Innovation in technologies, products, processes, equipment and services for primary, secondary and tertiary packaging solutions and the packaging and assembly of finished drug products. Including but not limited to, vials, ampules, blister packs, cartons, containers, tamper-proof packaging, labelling systems, track and trace, machinery, anticounterfeiting measures and solutions which prioritise patient centricity and adherence.

 

Criteria

Innovation
Does the entry introduce a new idea, device, method, or service to the market? Will it inspire future development?

Purpose
Does it achieve what it was intended to achieve? Does it offer a significant improvement on existing market solutions?

Sustainability
Has the entry been created with sustainability in mind? Does it seek to reduce carbon emissions or environmental impact?

Problem-solving
Does it solve a problem? Does it address an issue in an effective way?

Competitive Advantage
Does it offer a competitive advantage in the market and within its category?


Judges:
Pascale Gauthier, Pharmacist, PhD, Auvergne University
Michael Nieuwesteeg, Managing Director, NVC Packaging Centre
Bikash Chatterjee, President & CSO, Pharmatech
Karin von Kienlin, Partner & Managing Director, L.E.K. Consulting GmbH

Supply Chain Excellence

Innovation in technologies, products, processes, and services for ensuring the safe handling, security and tracking of drug substances, raw materials, and finished drug products. Including, but not limited to, supply chain optimisation, audits, temperature-controlled logistics, transport services, shipping and storage, anticounterfeiting, inventory management, demand forecasting and distribution channels.

 

Criteria

Innovation
Does the entry introduce a new idea, device, method, or service to the market? Will it inspire future development?

Purpose
Does it achieve what it was intended to achieve? Does it offer a significant improvement on existing market solutions?

Problem-solving
Does it solve a problem? Does it address an issue in an effective way?

Competitive Advantage
Does it offer a competitive advantage in the market and within its category?


Judges:
Emil Ciurczak, President, Doramaxx Consulting
Bikash Chatterjee, President & CSO, Pharmatech
Dave Malenfant, Executive Supply Chain Professional, Consultant Mentor, Founder and CEO, MDM Consulting
Bob Brooks, Phorum Director, BioPhorum
Molly Bowman, Head of Strategy for Pharmaceutical Supply Chain Management, Clarivate

Sustainability

Recognition of sustainable manufacturing, production or development in the pharmaceutical industry. Including but not limited to, innovative approaches to reducing environmental impact, waste and carbon emissions, energy or utility saving solutions, sustainable and collaborative product development, plastic reduction, improved recyclability or lifecycle management, implementation of circular economy initiatives, innovative use of materials, safeguarding of workers, and programmes or initiatives which seek to improve diversity and inclusion.

 

Criteria

Innovation
Does the entry introduce a new idea, material, device, method, or service to the market? Will it inspire future development?

Purpose
Does it achieve what it was intended to achieve? Does it offer a proven improvement on existing market solutions?

Environmental Impact
Does the entry offer a demonstrable improvement in reducing carbon emissions?

Competitive Advantage
Does it offer a competitive advantage in the market and within its category?


Judges:
Enric Bosch Rado, Senior EHS Manager - Supplier Qualification and Auditing, Boehringer Ingleheim
Emil Ciurczak, President, Doramaxx Consulting
Duncan Emerton, Consulting & Analytics, Citeline
Nicola Coles, Director - Sustainability, BioPhorum
Viju Vasishta, Sustainable Materials & Packaging Lead, PA Consulting
Mihaela Militaru, Senior Director EU Patient Insights & Advocacy, Oncology Healthcare Government & Public Affairs, Merck
Verena Ahnert, Partner - EA Kristina Mifsud, L.E.K. Consulting GmbH
Anita Vasilevska, Technical Marketing Manager, IMCD

Regulatory and Compliance

Innovation in technologies, products, processes, and services designed to aid and ensure compliance with standards, mandates, and guidance documents established by regulatory authorities.Including, but not limited to, consulting services, development of consortia and industry groups, reference standards, educational programs, case studies, technologies, platforms and equipment.

 

Criteria

Innovation
Does the entry introduce a new idea, method, or service to the market? Will it inspire future development?

Process Excellence
Does the entry offer an improved process, leading to better outcomes and results?

Problem-solving
Does it solve a problem? Does it address an issue in an effective way?

Competitive Advantage
Does it offer a competitive advantage in the market and within its category?


Judges:
Orlaith Ryan, CTO, Shorla Pharma
Duncan Emerton, Consulting & Analytics, Citeline
Mayur Patel, Associate Partner, PA Consulting
Alison Robinson, Phorum Director, BioPhorum

CEO of the Year

C-Suite Executives of SME, Large Pharma/Biopharma or service providers are eligible for nomination. Attributes to be considered include, but are not limited to, financial performance, product performance, global reach, leadership skills, management capability, charitable initiatives, sustainability, regulatory compliance, profitability, vision, marketing, acquisitions, corporate strategy, and financing.

 

Criteria

Dynamism
Is the nominee an exemplary leader with a strong desire to achieve – are they compelling and progressive? How have they demonstrated exceptional leadership?

Achievements
Has the CEO achieved or accomplished sustained growth, improved performance, implemented robust strategies, engaged staff and customers in their current role or throughout the course of their career?

Leadership
Has the CEO demonstrated consistent personal strengths and attributes that makes them an extraordinary leader?

Contribution to the Wider Industry
Is the CEO committed to the development of the broader pharma industry – this could involve donating goods, funding, time, market insights business intelligence, or contributing to educational programmes.


Judges:
Amira Ghozali, Director, Strategy and Market Intelligence, Aptar Pharma
Thomas Kern, Managing Partner, Vinc - Life Sciences Strategic Transaction Advisory
Dan Stanton, Editorial Director, Informa Connect Life Sciences
Elisabeth Stampa, President Medicines for Europe and Chair, Medichem SA

Start-up Initiative

A new category for 2023, the Start-Up Initiative award seeks to recognise Start-Ups and SMEs driving value and innovation across the pharma value chain. We are looking for entries which demonstrate a clear promise of innovation, growth or sustainable development in pharma.

 

We understand that Start-Ups are often at different stages of development, and accept entries across proof of concept, protype or commercialised stage.

 

Entries are reserved exclusively for organisations participating in the CPHI Start-Up Market. If you are a Start-Up who would like to take part, please visit our Start-Ups page here for more information.

 

Criteria

Innovation:
Does the entry introduce a new idea, device, method or service to the market? Does it drive or facilitate efficiencies?

Industry disruptor:
Does this product have the potential to disrupt the industry or become the future benchmark for innovation and change?

Sustainability:
Is this product created with sustainability in mind? Does it aim to reduce carbon emissions, waste or environmental impact?

Patient centricity:
Does the product or solution offer a significant improvement or development for patients and end users?


Judges:
Amira Ghozali, Director, Strategy and Market Intelligence, Aptar Pharma
Wayne Weiner, President, Pharmatech Solutions LLC
Thomas Kern, Managing Partner, Vinc - Life Sciences Strategic Transaction Advisory
Pascale Gauthier, Pharmacist, PhD, Auvergne University
Emil Ciurczak, President, Doramaxx Consulting
Duncan Emerton, Consulting & Analytics, Citeline
Harsh Chauhan, Assistant Professor, Creighton University
Vincent Galand, Head of BD & Partnerships France, Observia

At the Heart of Pharma

This award looks to recognise companies, individuals and initiatives which nurture philanthropic, ethical and community-based ventures. We welcome entries which prioritise patient engagement and centricity, promote corporate social responsibility and improve healthcare accessibility or equity.

 

Criteria:

Innovation
Does the entry introduce a new idea, method, or service to the market?

Contribution to the Wider Industry
Does the entry demonstratea commitment to improving the pharma industry? Will it inspire future development?

Problem-solving
Does it solve a problem? Does it address an issue in an effective way?

Outcomes
Can the entry demonstrate sufficient evidence of improved outcomes, through data, case studies or testimonials?


Judges:
Fiona Barry, Editor-in-Chief and Director – PharmSource, GlobalData
Phillip Broadwith, Business Editor, Royal Society of Chemistry
Vincent Galand, Head of BD & Partnerships France, Observia
Mihaela Militaru, Senior Director EU Patient Insights & Advocacy, Oncology Healthcare Government & Public Affairs, Merck
Verena Ahnert, Partner - EA Kristina Mifsud, L.E.K. Consulting GmbH

NEW! Woman of the Year

An award to recognise women leaders in pharma. This category celebrates those who seek to inspire and uplift colleagues and peers, are committed to supporting diversity and inclusion and act as an advocate for progression and change in pharma. 

 

Criteria:

Leadership & Collaboration 
Is the nominee an exemplary leader, are they compelling and progressive? Do they give a voice or platform to others through their leadership style? 

 

Advancement 
How has the entrant broken down barriers to create or facilitate opportunities for women in industry? Have they led initiatives or projects which promote or empower underrepresented communities? 

Inspiration 
Is the nominee seen as a role model within their organisation, or across the wider industry? Are they confident, and open to tackling difficult conversations or challenging the status quo? 

Contribution to the Wider Industry 
Has the nominee contributed to the development of a more diverse pharma industry – examples may include, thought leadership, mentorship, involvement with associations, employee initiatives, volunteering, coaching etc. 


Judges:
Amira Ghozali, Director, Strategy and Market Intelligence, Aptar Pharma
Demetria Johnson, D&I Early in Career Partner - Americas, Genetech
Sanobar Syed, Associate Director- Market Insights and Strategy, BeiGene
Thomas Kern, Managing Partner, Vinc - Life Sciences Strategic Transaction Advisory
Orlaith Ryan, CTO, Shorla Pharma
Vincent Galand, Head of BD & Partnerships France, Observia
Viju Vasishta, Sustainable Materials & Packaging Lead, PA Consulting
Alison Robinson, Phorum Director, BioPhorum
Mihaela Militaru, Senior Director EU Patient Insights & Advocacy, Oncology Healthcare Government & Public Affairs, Merck
Elisabeth Stampa, President Medicines for Europe and Chair, Medichem SA
Anita Vasilevska, Technical Marketing Manager, IMCD

NEW! Future Leader

Each generation brings a different perspective, and this award seeks to recognise those rising stars, the pharma leaders of the future bringing a fresh approach to the industry,  

 

Criteria

We invite applications from candidates with a minimum of five years’ work experience within a pharma, biopharma company, academic or research institution. The entrant should be no older than 35 by the time of the Awards ceremony on 8th October 2024. 

 

Leadership & Collaboration 
What makes the entrant stand out as an emerging talent or leader? Examples could relate to managing teams, inspiring colleagues, taking on additional roles and responsibilities, noteworthy contributions to out-of-the-box projects, introducing new ideas, methodologies or initiatives or exceptional academic achievements. 

Recognition 
How has the nominee demonstrated outstanding performance in their role? Have they received external or internal awards or nominations, or been endorsed by colleagues or clients for their work? 

Personal Brand 
What steps has the nominee taken to build their profile, both internally within their organisations and externally? Have they contributed to scientific journals, undertaken thought leadership roles or built a significant social media presence?

Industry Involvement 
Is the nominee committed to the development of the broader pharma industry – this could involve participating in conferences or events, being a part of industry groups or associations, leading employee initiatives, volunteering, coaching etc.


Judges:
Amira Ghozali, Director, Strategy and Market Intelligence, Aptar Pharma
Demetria Johnson, D&I Early in Career Partner - Americas, Genetech
Sanobar Syed, Associate Director- Market Insights and Strategy, BeiGene
Harsh Chauhan, Assistant Professor, Creighton University
Phillip Broadwith, Business Editor, Royal Society of Chemistry
Dave Malenfant, Executive Supply Chain Professional, Consultant Mentor, Founder and CEO, MDM Consulting
Mihaela Militaru, Senior Director EU Patient Insights & Advocacy, Oncology Healthcare Government & Public Affairs, Merck

pharma awards
Become the benchmark for success
Submit your entry today and set the industry standard. The awards are free to enter, and we welcome entries across multiple categories.
Sponsorship
A global audience
Sponsorship
Align your brand with the industry's best and brightest as a sponsor for the CPHI Pharma Awards. With a comprehensive range of packages to suit any budget, it's time to put yourself in front of pharma's decision-makers.